文献速递肺结节与肺癌

60例非筛查检出的肺癌体内生长:CT研究

In vivo growth of 60 non-screening detected lung cancers: a computed tomography study.
PubMed 文献 · Eur Respir J · 2018-04-12

本研究在非筛查背景下分析60例病理证实的肺癌的CT生长模式。随机截距随机斜率混合模型分析证实,实性和亚实性肺癌生长均最符合指数模型,亚实性病变进展较慢,基线病灶体积与生长无关。这为体积倍增时间分析中的指数生长假设提供了常规诊疗环境下的首个实验依据。

要点

  • 实性和亚实性肺癌生长均最符合指数模型
  • 亚实性病变通常比实性病变进展更慢
  • 基线病灶体积与生长无关,小病灶并不长得更慢

核心结论

  • 实性和亚实性肺癌生长均最符合指数模型
  • 为体积倍增时间分析中的指数生长假设提供了常规诊疗环境下的首个实验依据

研究设计与样本

  • 来自两个学术中心的60例病理证实的肺癌,诊断前至少进行三次影像检查
  • 使用专用软件分析生长行为,采用随机截距随机斜率混合模型检验最符合的生长模式

主要发现

  • 亚实性和实性肺癌生长均最符合指数模型
  • 亚实性病变通常比实性病变进展更慢
  • 基线病灶体积与生长无关,较小病灶并不比较大病灶生长更慢

临床怎么用

  • 在常规诊疗环境中,体积倍增时间分析所依据的指数生长假设获得实验支持

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Current pulmonary nodule management guidelines are based on nodule volume doubling time, which assumes exponential growth behaviour. However, this is a theory that has never been validated in vivo in the routine-care target population. This study evaluates growth patterns of untreated solid and subsolid lung cancers of various histologies in a non-screening setting.Growth behaviour of pathology-proven lung cancers from two academic centres that were imaged at least three times before diagnosis (n=60) was analysed using dedicated software. Random-intercept random-slope mixed-models analysis was applied to test which growth pattern most accurately described lung cancer growth. Individual growth curves were plotted per pathology subgroup and nodule type.We confirmed that growth in both subsolid and solid lung cancers is best explained by an exponential model. However, subsolid lesions generally progress slower than solid ones. Baseline lesion volume was not related to growth, indicating that smaller lesions do not grow slower compared to larger ones.By showing that lung cancer conforms to exponential growth we provide the first experimental basis in the routine-care setting for the assumption made in volume doubling time analysis.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Mets OM, Chung K, Zanen P, et al. In vivo growth of 60 non-screening detected lung cancers: a computed tomography study. Eur Respir J. 2018. PMID: 29650547. doi:10.1183/13993003.02183-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。